Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb;34(2):233-244.
doi: 10.1111/tri.13789. Epub 2021 Jan 15.

Cellular therapies in organ transplantation

Martin J Hoogduijn  1 , Fadi Issa  2 , Federica Casiraghi  3 , Marlies E J Reinders  1
Affiliations
Review

Cellular therapies in organ transplantation

Martin J Hoogduijn et al. Transpl Int. 2021 Feb.

Abstract

Cellular therapy is a promising tool for improving the outcome of organ transplantation. Various cell types with different immunoregulatory and regenerative properties may find application for specific transplant rejection or injury-related indications. The current era is crucial for the development of cellular therapies. Preclinical models have demonstrated the feasibility of efficacious cell therapy in transplantation, early clinical trials have shown safety of several of these therapies, and the first steps towards efficacy studies in humans have been made. In this review, we address the current state of the art of cellular therapies in clinical transplantation and discuss monitoring tools and endpoints for these studies.

Keywords: cell therapy; immunomodulation; mesenchymal stromal cells; regeneration; regulatory T-cells; regulatory macrophages.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cyclosporin in cadaveric renal transplantation: one‐year follow‐up of a multicentre trial. Lancet 1983; 2: 986. - PubMed
    1. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225. - PubMed
    1. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715. - PubMed
    1. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326. - PubMed
    1. Soltys KA, Setoyama K, Tafaleng EN, et al Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol 2017; 66: 987. - PMC - PubMed